Gamida Cell Ltd.
GMDA · NASDAQ
3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.00 | -0.00 | 0.22 | -0.23 |
| FCF Yield | -405.31% | -26.34% | -14.52% | -11.07% |
| EV / EBITDA | -2.46 | -6.11 | -8.87 | -12.59 |
| Quality | ||||
| ROIC | 34.50% | -19.14% | -18.30% | -19.56% |
| Gross Margin | -305.39% | -64.54% | 6.98% | 0.00% |
| Cash Conversion Ratio | 1.15 | 1.75 | 12.23 | 0.69 |
| Growth | ||||
| Revenue 3-Year CAGR | 1,387,892.55% | 1,212,725.40% | 876,238.09% | -100.00% |
| Free Cash Flow Growth | -47.01% | 15.48% | 15.52% | 4.82% |
| Safety | ||||
| Net Debt / EBITDA | -2.22 | -2.19 | -1.44 | -1.96 |
| Interest Coverage | 0.00 | -1.70 | 0.00 | -1.46 |
| Efficiency | ||||
| Inventory Turnover | 1.84 | 0.96 | 0.27 | 0.05 |
| Cash Conversion Cycle | 17.37 | 131.70 | 185.29 | -41.67 |